Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females
Cindee F. Robles, Marissa Z. McMackin, Katharine L. Campi, et al.
Behavioural Brain Research (2014) Vol. 262, pp. 84-93
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

The Kappa Opioid Receptor: From Addiction to Depression, and Back
Laurence Lalanne, Gülebru Ayrancı, Brigitte L. Kieffer, et al.
Frontiers in Psychiatry (2014) Vol. 5
Open Access | Times Cited: 205
Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction
Elena H. Chartoff, Maria Mavrikaki
Frontiers in Neuroscience (2015) Vol. 9
Open Access | Times Cited: 119
Neuropeptide Regulation of Signaling and Behavior in the BNST
Thomas L. Kash, Kristen E. Pleil, Catherine A. Marcinkiewcz, et al.
Molecules and Cells (2014) Vol. 38, Iss. 1, pp. 1-13
Open Access | Times Cited: 106
Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders
Hugo A. Tejeda, Antonello Bonci
Brain Research (2018) Vol. 1713, pp. 91-101
Closed Access | Times Cited: 101
Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction
Anushree N. Karkhanis, Katherine M. Holleran, Sara R. Jones
International review of neurobiology (2017), pp. 53-88
Closed Access | Times Cited: 98
Targeting opioid dysregulation in depression for the development of novel therapeutics
Caroline A. Browne, Irwin Lucki
Pharmacology & Therapeutics (2019) Vol. 201, pp. 51-76
Open Access | Times Cited: 84
A review of the effects of different types of social behaviors on the recruitment of neuropeptides and neurotransmitters in the nucleus accumbens
Johnathan M. Borland
Frontiers in Neuroendocrinology (2025), pp. 101175-101175
Closed Access | Times Cited: 1
Endogenous opiates and behavior: 2014
Richard J. Bodnar
Peptides (2015) Vol. 75, pp. 18-70
Closed Access | Times Cited: 79
Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol
Rachel I. Anderson, Howard C. Becker
Alcoholism Clinical and Experimental Research (2017) Vol. 41, Iss. 8, pp. 1402-1418
Open Access | Times Cited: 73
Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice
Rachel I. Anderson, Marcelo F. Lopez, William C. Griffin, et al.
Neuropsychopharmacology (2018) Vol. 44, Iss. 6, pp. 1084-1092
Open Access | Times Cited: 69
Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion
Antony D. Abraham, Selena S. Schattauer, Kathryn L. Reichard, et al.
Journal of Neuroscience (2018) Vol. 38, Iss. 37, pp. 8031-8043
Open Access | Times Cited: 66
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders
Moriah L. Jacobson, Caroline A. Browne, Irwin Lucki
The Annual Review of Pharmacology and Toxicology (2020) Vol. 60, Iss. 1, pp. 615-636
Closed Access | Times Cited: 56
Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal
Matthew B. Pomrenze, Daniel F. Cardozo Pinto, Peter A. Neumann, et al.
Neuron (2022) Vol. 110, Iss. 24, pp. 4125-4143.e6
Open Access | Times Cited: 36
Biased agonism at kappa opioid receptors: Implication in pain and mood disorders
Shalini Dogra, Prem N. Yadav
European Journal of Pharmacology (2015) Vol. 763, pp. 184-190
Closed Access | Times Cited: 52
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
Shane W Kaski, Allison White, Joshua Gross, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 371, Iss. 2, pp. 487-499
Open Access | Times Cited: 43
Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation
Sineadh M. Conway, Daniel J. Puttick, Shayla Russell, et al.
Neuropharmacology (2018) Vol. 146, pp. 231-241
Open Access | Times Cited: 45
Acute inhibition of kappa opioid receptors before stress blocks depression-like behaviors in California mice
Alexia V. Williams, Abigail Laman-Maharg, Crystal V. Armstrong, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 86, pp. 166-174
Open Access | Times Cited: 43
Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence
Laurence Lalanne, Gülebru Ayrancı, Dominique Filliol, et al.
Addiction Biology (2016) Vol. 22, Iss. 4, pp. 1010-1021
Open Access | Times Cited: 41
Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys
Sally L. Huskinson, Donna M. Platt, Morgan Brasfield, et al.
Psychopharmacology (2020) Vol. 237, Iss. 7, pp. 2075-2087
Open Access | Times Cited: 32
Interaction of CRF and Kappa Opioid Systems on GABAergic Neurotransmission in the Mouse Central Amygdala
Maeng-Hee Kang-Park, Brigitte L. Kieffer, Amanda J. Roberts, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 355, Iss. 2, pp. 206-211
Open Access | Times Cited: 39
The impact of sex as a biological variable in the search for novel antidepressants
Alexia V. Williams, Brian C. Trainor
Frontiers in Neuroendocrinology (2018) Vol. 50, pp. 107-117
Open Access | Times Cited: 35
Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies
Hiroshi Nagase, Naoshi Yamamoto, Masahiro Yata, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 3, pp. 1018-1040
Closed Access | Times Cited: 34
Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers
David Matuskey, Mark Dias, Mika Naganawa, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 10, pp. 1714-1719
Open Access | Times Cited: 30
Mean Girls: Social Stress Models for Female Rodents
Jace X. Kuske, Brian C. Trainor
Current topics in behavioral neurosciences (2021), pp. 95-124
Open Access | Times Cited: 20
Systemic kappa opioid receptor antagonism accelerates reinforcement learning via augmentation of novelty processing in male mice
Zahra Z. Farahbakhsh, Keaton Song, Hannah E. Branthwaite, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 6, pp. 857-868
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top